Compounds > ciprofloxacin

ciprofloxacin and (9R)-9-chloro-11,17-dihydroxy-17-(2-hydroxy-1-oxoethyl)-10,13,16-trimethyl-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-3-one

ciprofloxacin has been researched along with (9R)-9-chloro-11,17-dihydroxy-17-(2-hydroxy-1-oxoethyl)-10,13,16-trimethyl-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-3-one in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chan, HK; Heng, D; Lee, SH; Ng, WK; Tan, RB; Teo, J; Zhao, Y1

Other Studies

1 other study(ies) available for ciprofloxacin and (9R)-9-chloro-11,17-dihydroxy-17-(2-hydroxy-1-oxoethyl)-10,13,16-trimethyl-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-3-one

ArticleYear
Steroid-decorated antibiotic microparticles for inhaled anti-infective therapy.
    Journal of pharmaceutical sciences, 2014, Volume: 103, Issue:4

    Topics: Administration, Inhalation; Anti-Bacterial Agents; Bacterial Infections; Beclomethasone; Ciprofloxacin; Dry Powder Inhalers; Glucocorticoids; Humans; Klebsiella pneumoniae; Pneumonia; Powders; Pseudomonas aeruginosa; Pulmonary Disease, Chronic Obstructive; Staphylococcus aureus

2014